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Comparison of different cohorts of SIV-infected rhesus
macaques that control viremia may help to identify the
mechanisms that prevent progression towards AIDS. We
study 3 groups of macaques able to control viremia to var-
ious extents. Group 1 was infected with live-attenuated
Rev-independent SIV is able to persistently control
viremia over more than 7 years. Group 2 are live-attenu-
ated SIV-infected macaques additionally challenged with
pathogenic SIVmac251 and controls the challenge to var-
ious levels (<105 copies/ml) for more than 4 years. Group
3 are SIVmac251-infected animals therapeutically immu-
nized using DNA vectors during ART. These animals con-
trol viremia after release from ART for more than 18
months (<104 copies/ml). Animals in groups 1 and 2
developed long-lasting humoral and cellular immune
responses. Animals in group 3 have persistent increases in
cellular and humoral responses leading to virus contain-
ment and slower onset of disease. The understanding of
the underlying mechanism leading to protective immune
responses of these 3 cohorts of 'controllers' will be useful
for rational vaccine design.
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